CysLT(1) leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors

Montelukast and pranlukast are orally active leukotriene receptor antagonists selective for the CysLT(1) receptor. Conversely, the hP2Y(1,2,4,6,11,12,13,14) receptors represent a large family of GPCRs responding to either adenine or uracil nucleotides, or to sugar-nucleotides. Montelukast and pranlu...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Biochem Pharmacol
Egile Nagusiak: Mamedova, Liaman, Capra, Valérie, Accomazzo, Maria Rosa, Gao, Zhan-Guo, Ferrario, Silvia, Fumagalli, Marta, Abbracchio, Maria P., Rovati, G. Enrico, Jacobson, Kenneth A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2005
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4967539/
https://ncbi.nlm.nih.gov/pubmed/16280122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2005.10.003
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak